Antibacterial Activitiy of Triterpeniod Compounds

Abstract

The goal of the study was to ascertain whether particular pathogenic bacteria could be inhibited by triterpeniod substances obtained from Rosmarinus officinalis (rosemary) extracts. The time frame for completing this construction was July 2023–April 2024. At the beginning, 100 specimens were taken from patients who were undergoing treatment at the Burn Cure Center in Nineveh Governorate, Iraq Routine biochemical testing were used to determine burn infections caused by bacteria, and the Vitek2 compact system was used to confirm the diagnosis. Acinetobacter baumani and Pseudomonas auroginosa were the most common isolates. In order to extract the substance, rosemary (R. officinalis) leaves were air-dried in the shade and then processed into a fine powder using a grinding machine. A soxhlet device was used to extract 50 g of powdered leaves for six hours at 40–60 °C using 250 ml of 75% petroleum ether. Afterwards, the mixture was dried out at 40°C in a rotating evaporator. After being weighed, the extract residue was stored until needed. Using gas chromatography/mass spectrometry (GC/MS), the crude extract was examined. Ursolic acid (1.38), oleanolic acid (3.27), and other triterpeniod substances with varying ratios were identified by GC-MS analysis. The antibacterial activity of triterpeniod compounds was assessed at concentrations of 12.5%, 25%, 50%, and 100% using the well-diffusion Kirby-Bauer method. The test was evaluated in comparison to six bacterial strains. The results indicated that staphylococcus aureus (50%:22mm – 100%: 26mm), staphylococcus haemolyticus (100%: 17mm), and Acinetobacter baumani (50%:18mm – 100%: 22mm) had the highest inhibitory.